Skip to main content
SpringerLink
Log in

Preoperative Management of Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  • Original Paper
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Elias D, Goéré D, Dumont F, Honoré C, Dartigues P, Stoclin A, Malka D, Boige V, Ducreux M (2014) Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. Eur J Cancer 50(2):332–340

    Article  CAS  PubMed  Google Scholar 

  2. Mohamed F, Moran BJ (2009) Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J 15(3):196–199 Review. PMID: 19556904

    Article  PubMed  Google Scholar 

  3. Shime N, Lee M, Hatanaka T (1994) Cardiovascular changes during continuous hyperthermic peritoneal perfusion. Anesth Analg 78:938–942

    Article  CAS  PubMed  Google Scholar 

  4. Schmidt C, Creutzenberg M, Piso P, et al. (2008) Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia 63:389–395

    Article  CAS  PubMed  Google Scholar 

  5. Esquivel J, Angulo F, Bland RK, et al. (2000) Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open “coliseum technique”. Ann Surg Oncol 7:296–300

    Article  CAS  PubMed  Google Scholar 

  6. Glehen O (2003) Gilly FNQuantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 12(3):649–671

    Article  PubMed  Google Scholar 

  7. Ghaferi AA, Birkmeyer JD, Dimick JB (2009) Variation in hospital mortality associated with inpatient surgery. N Engl J Med 361(14):1368–1375

    Article  CAS  PubMed  Google Scholar 

  8. Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. International Seminars in Surgical Oncology : ISSO 2:3. doi:10.1186/1477-7800-2-3

    Article  PubMed  PubMed Central  Google Scholar 

  9. Chua TC, Moran BJ, Sugarbaker PH, et al. (2012) Early- and long-term outcome data of patients with pseudomyxomaperitonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456

    Article  PubMed  Google Scholar 

  10. Saxena A, Yan TD, Chua TC, Morris DL (2010) Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxomaperitonei. Ann Surg Oncol 17(5):1291–1301. doi:10.1245/s10434-009-0875-9

    Article  PubMed  Google Scholar 

  11. Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Lung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the task force for preoperative cardiac Risk Assessment And Perioperative Cardiac Management in non-cardiac surgery of the European Society Of Cardiology (ESC) and European Society Of Anaesthesiology (ESA). Eur Heart J 30(22):2769–2812

    Article  PubMed  Google Scholar 

  12. Froehlich JB, Fleisher LA (2009) Noncardiac surgery in the patient with heart disease. Anesthesiol Clin 27(4):649–671

    Article  PubMed  Google Scholar 

  13. Hammill BG, Curtis LH, Bennett-Guerrero E, O'Connor CM, Jollis JG, Schulman KA, Hernandez AF (2008) Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 108(4):559–567

    Article  PubMed  Google Scholar 

  14. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey DE Jr, Cross JT Jr, Fitterman N, Sherif KD, Weiss KB (2006) Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College Of Physicians. Ann Intern Med 144(8):575–580

    Article  PubMed  Google Scholar 

  15. Cook MW, Lisco SJ (2009) Prevention of postoperative pulmonary complications. IntAnesthesiol Clin 47(4):65–88

    Article  Google Scholar 

  16. Gouy S, Chereau E, Custodio AS, Uzan C, Pautier P, Haie-Meder C, Duvillard P, Morice P (2010) Surgicalprocedures and morbidities of diaphragmaticsurgery in patients undergoing initial or interval debulkingsurgery for advanced-stage ovarian cancer. J Am Coll Surg 210(4):509–514. doi:10.1016/j.jamcollsurg.2010.01.011

    Article  PubMed  Google Scholar 

  17. Ahmed S, Levine EA, Randle RW, et al. (2014) Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Annals of surgical oncology. 21(13):4226–4231. doi:10.1245/s10434-014-3891-3

    Article  PubMed  PubMed Central  Google Scholar 

  18. Westwood K, Griffin M, Roberts K, Williams M, Yoong K, Digger T (2007) Incentive spirometry decreases respiratory complications following majorabdominal surgery. Surgeon 5(6):339–342

    Article  CAS  PubMed  Google Scholar 

  19. Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A (2007) Malnutrition among gynaecological cancer patients. Eur J Clin Nutr 61:642–646

    Article  CAS  PubMed  Google Scholar 

  20. Andreyev HJ, Norman AR, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34(4):503–509

    Article  CAS  PubMed  Google Scholar 

  21. Laviano A, Meguid MM (1996) Nutritional issues in cancer management. Nutrition 12(5):358–371 Review. PMID: 8875522

    Article  CAS  PubMed  Google Scholar 

  22. McQuellon R, Gavazzi C, Piso P, Swain D, Levine E (2008) Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. J SurgOncol 98(4):300–305. doi:10.1002/jso.21050

    Google Scholar 

  23. Martindale RG, Maerz LL (2006) Management of perioperative nutrition support. Curr Opin Crit Care 12(4):290–294 Review. PMID: 16810037

    Article  PubMed  Google Scholar 

  24. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. (1987) What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 11:8–13. doi:10.1177/014860718701100108

    Article  CAS  PubMed  Google Scholar 

  25. Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, Falkmer UG (2002) Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16:33–42. doi:10.1191/0269216302pm486oa

    Article  PubMed  Google Scholar 

  26. Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P, DGEM (German Society for Nutritional Medicine), Jauch KW, Kemen M, Hiesmayr JM, Horbach T, Kuse ER, Vestweber KH, ESPEN (European Society for Parenteral and Enteral Nutrition) (2006) ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25(2):224–244 PMID:16698152

    Article  CAS  PubMed  Google Scholar 

  27. Druyan ME, Compher C, Boullata JI, Braunschweig CL, George DE, Simpser E, Worthington PA, American Society for Parenteral and Enteral Nutrition Board of Directors (2012) Clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients: applying the GRADE system to development of A.S.P.E.N. clinical guidelines. J Parenter Enteral Nutr 36(1):77–80. doi:10.1177/0148607111420157 PMID: 22179521

    Article  Google Scholar 

  28. Vashi PG, Gupta D, Lammersfeld CA, et al. (2013) The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy. Nutrition Journal. 12:118. doi:10.1186/1475-2891-12-118

    Article  PubMed  PubMed Central  Google Scholar 

  29. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655

    Article  CAS  PubMed  Google Scholar 

  30. Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncology. 2:187–193

    Article  CAS  Google Scholar 

  31. Dubé P, Sideris L, Law C, et al. (2015) Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Current Oncology. 22(2):e100–e112. doi:10.3747/co.22.2058

    Article  PubMed  PubMed Central  Google Scholar 

  32. Tabrizian P, Jibara G, Shrager B, Franssen B, Yang MJ, Sarpel U, Hiotis S, Labow D (2013 Sep) Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. Surg Oncol 22(3):184–189. doi:10.1016/j.suronc.2013.06.001

  33. Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ (2009) Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg 208(1):53–61

    Article  PubMed  Google Scholar 

  34. Tokunaga M, Hiki N, Fukunaga T, Ogura T, Miyata S, Yamaguchi T (2009) Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg 96(5):496–500

    Article  CAS  PubMed  Google Scholar 

  35. Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA (2013) Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors. Ann Surg Oncol 20(12):3899–3904. doi:10.1245/s10434-013-3087-2

    Article  PubMed  PubMed Central  Google Scholar 

  36. Polanco PM, Sanchez AI, Ramalingam L, Jones H, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA (2014) Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms? Ann Surg Oncol 21(12):3963–3969. doi:10.1245/s10434-014-3807-2

    Article  PubMed  Google Scholar 

  37. McPartland SJ, Goodman MD (2014) The effect of elevated body mass index on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann SurgOncol 21(5):1463–1467. doi:10.1245/s10434-013-3280-3

    Google Scholar 

  38. Polanczyk CA, Marcantonio E, Goldman L, Rohde LE, Orav J, Mangione CM, et al. (2001) Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med 134:637–643

    Article  CAS  PubMed  Google Scholar 

  39. Votanopoulos KI, Newman NA, Russell G, et al. (2013) Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality. Ann SurgOncol 20(11). doi:10.1245/s10434-013-3053-z

  40. Huang Y, Alzahrani NA, Alzahrani SE, Zhao J, Liauw W, Morris DL (2015) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly. World Journal of Surgical Oncology 13:262. doi:10.1186/s12957-015-0682-7

    Article  PubMed  PubMed Central  Google Scholar 

  41. Spiliotis J, Halkia E, Boumis V, Vassiliadou D, Pagoulatou A, Efstathiou E (2014) Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly. Intern J Surg Oncol 2014:987475

    CAS  Google Scholar 

  42. Mueller H, Hahn M, Simsa J (2007) Cytoreductive surgery in the elderly patients–is it feasible? Hepato-Gastroenterology 55(88):2005–2011

    Google Scholar 

  43. Macri A, Saladino E, Trimarchi G, Bartolo V, Rossitto M, Cannao A, et al. (2011) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in elderly patients. In Vivo 25(4):687–690

    PubMed  Google Scholar 

  44. McQuellon RP, Loggie BW, Fleming RA, et al. (2001) Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27:65–73

    Article  CAS  PubMed  Google Scholar 

  45. Duckworth KE, McQuellon RP, Russell GB, et al. (2012) Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). J Surg Oncol 106:376–380

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lim C, Tordjmann D, Gornet JM, et al. (2010) Prospective study of quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using oxaliplatin for peritoneal carcinomatosis. Bull Cancer 97:1053–1060

    CAS  PubMed  Google Scholar 

  47. McQuellon RP, Danhauer SC, Russell GB, et al. (2007) Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 14:1105–1113

    Article  PubMed  Google Scholar 

  48. McQuellon RP, Loggie BW, Lehman AB, et al. (2003) Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10:155–162

    Article  PubMed  Google Scholar 

  49. Tsilimparis N, Bockelmann C, Raue W, et al. (2013) Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Ann Surg Oncol 20:226–232

    Article  PubMed  Google Scholar 

  50. Hill AR, McQuellon RP, Russell GB, et al. (2011) Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol 18:3673–3679

    Article  PubMed  PubMed Central  Google Scholar 

  51. González-Moreno S, Ortega-Pérez G, González-Bayón L (2009) Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy. J SurgOncol. 100(4):287–292. doi:10.1002/jso.21325

    Google Scholar 

  52. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374

    Article  CAS  PubMed  Google Scholar 

  53. Sugarbaker PH (2009) Epithelial appendiceal neoplasms. Cancer J 15:225–235. doi:10.1097/PPO.0b013e3181a9c781

    Article  PubMed  Google Scholar 

  54. Esquivel J, Garcia SS, Hicken W, Seibel J, Shekitka K, Trout R (2014) Evaluation of a new staging classification and a peritoneal surface disease severity score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination. J Surg Oncol 110(6):656–660. doi:10.1002/jso.23679

    Article  PubMed  Google Scholar 

  55. Yoon W, Alame A, Berri R (2014) Peritoneal surface disease severity score as a predictor of resectability in the treatment of peritonealsurface malignancies. Am J Surg 207(3):403–407 discussion 406-7. doi:10.1016/j.amjsurg.2013.09.021

    Article  PubMed  Google Scholar 

  56. Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R (2014) The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol 21(13):4195–4201. doi:10.1245/s10434-014-3798-z

    Article  PubMed  Google Scholar 

  57. Pelz JO, Chua TC, Esquivel J, Stojadinovic A, Doerfer J, Morris DL, Maeder U, Germer CT, Kerscher AG (2010) Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to there trospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer 10:689. doi:10.1186/1471-2407-10-689

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Zmora O, Mahajna A, Bar-Zakai B, Rosin D, Hershko D, Shabtai M, Krausz MM, Ayalon A (2003) Colon and rectal surgery without mechanical bowel preparation: a randomized prospective trial. Ann Surg 237(3):363–367

    PubMed  PubMed Central  Google Scholar 

  59. Pena-Soria MJ, Mayol JM, Anula R, Arbeo-Escolar A, Fernandez-Represa JA (2008) Single-blinded randomized trial of mechanical bowel preparation for colon surgery with primary intraperitoneal anastomosis. J Gastrointest Surg 12(12):2103–2108 discussion 2108–2109

    Article  PubMed  Google Scholar 

  60. Bretagnol F, Panis Y, Rullier E, Rouanet P, Berdah S, Dousset B, Portier G, Benoist S, Chipponi J, Vicaut E (2010) Rectal cancer surgery with or without bowel preparation: the French GRECCAR III multicenter single-blinded randomized trial. Ann Surg 252(5):863–868

    Article  PubMed  Google Scholar 

  61. Pineda CE, Shelton AA, Hernandez-Boussard T, Morton JM, Welton ML (2008) Mechanical bowel preparation in intestinal surgery: a meta-analysis and review of the literature. J Gastrointest Surg 12(11):2037–2044

    Article  PubMed  Google Scholar 

  62. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP (1992) The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 326(5):281–286

    Article  CAS  PubMed  Google Scholar 

  63. Bratzler DW, Houck PM (2005) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 189(4):395–404

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, CHL CBCC cancer centre, Indore, M. P., 452008, India

    Rangole Ashvin

  2. Fortis Hospital, Bengaluru, India

    Bhatt Aditi

  3. CHL Hospitals, Indore, M. P., India

    Jain Nikhilesh

Authors
  1. Rangole Ashvin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bhatt Aditi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jain Nikhilesh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rangole Ashvin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ashvin, R., Aditi, B. & Nikhilesh, J. Preoperative Management of Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Indian J Surg Oncol 8, 573–579 (2017). https://doi.org/10.1007/s13193-016-0517-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0517-1

Search

Navigation